Promoting Fc-Fc interactions between anti-capsular antibodies provides strong immune protection against Streptococcus pneumoniae

Autor: Aguinagalde Salazar, Leire, den Boer, Maurits A, Castenmiller, Suzanne M, Zwarthoff, Seline A, de Haas, Carla, Aerts, Piet C, Beurskens, Frank J, Schuurman, Janine, Heck, Albert J R, van Kessel, Kok, Rooijakkers, Suzan H M, Afd Biomol.Mass Spect. and Proteomics, Sub Biomol.Mass Spectrometry & Proteom., Biomolecular Mass Spectrometry and Proteomics

Publikováno v: eLife, 12. eLife Sciences Publications

Streptococcus pneumoniae is the leading cause of community-acquired pneumonia and an important cause of childhood mortality. Despite the introduction of successful vaccines, the global spread of both non-vaccine serotypes and antibiotic-resistant str

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb979f2c5a20abbc4ddc4e9617e5c8d4
https://doi.org/10.7554/elife.80669

Two randomized trials of the effect of live attenuated influenza vaccine on pneumococcal colonization

Autor: Rylance, Jamie, de Steenhuijsen Piters, Wouter A.A., Mina, Michael J., Bogaert, Debby, French, Neil, Ferreira, Daniela M.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10691::8981c4870ef12cffe0c2a63ebe70c050
https://dspace.library.uu.nl/handle/1874/392256

Decreasing Incidence and Changes in Serotype Distribution of Invasive Pneumococcal Disease in Persons Aged Under 18 Years Since Introduction of 10-Valent and 13-Valent Conjugate Vaccines in Portugal, July 2008 to June 2012

Autor: S I, Aguiar, M J, Brito, A N, Horacio, J P, Lopes, M, Ramirez, J, Melo-Cristino, Isabel, Monteiro

Publikováno v: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)

Eurosurveillance. © 2007 - 2021. All rights reserved
The 10-valent pneumococcal conjugate vaccine (PCV10) became available in Portugal in mid-2009 and the 13-valent vaccine (PCV13) in early 2010. The incidence of invasive pneumococcal disease (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::451bb649600de5c29d8a215cc0336cca
https://hdl.handle.net/10400.17/2397

Use of pneumococcal polysaccharide vaccine in children: what is the evidence?

Autor: Borrow, Ray, Heath, Paul T, Siegrist, Claire-Anne

Publikováno v: Current Opinion in Infectious Diseases, Vol. 25, No 3 (2012) pp. 292-303

Pneumococcal glycoconjugate vaccines (PCVs) are now widely used in infant immunization schedules. These vaccines are also recommended for those at increased risk of pneumococcal infection and to provide optimal serotype coverage to those at increased

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1400::476ab2da142b0ad82acf56297b14c695
https://archive-ouverte.unige.ch/unige:31385

Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae

Autor: Jodie McVernon, Cynthia G. Whitney, E. Kim Mulholland, Caroline Trotter, Marie-Paule Kieny, Mary Ramsay, Joachim Hombach, David Goldblatt

Publikováno v: Vaccine, Vol. 26, No 35 (2008) pp. 4434-45

Conjugate vaccines exist that offer protection against disease caused by Haemophilus influenzae type b (Hib), and selected serogroups/serotypes of Neisseria meningitidis and Streptococcus pneumoniae. These vaccines are not only able to prevent seriou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58579541751c2e3c9327cea6c4479e65
https://pubmed.ncbi.nlm.nih.gov/18617296